Detected ·
Astrocyte Pharmaceuticals
$9.5M—
Astrocyte Pharmaceuticals completed a $9.5M Series B financing and advanced enrollment in its Phase 2 STARFAST trial for AST-004, a cerebroprotective treatment for concussion.
- Website
- —
- —
- Amount
- $9 500 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-10-01 04:03:43 UTC
- Signal ID
- 56152c89-c24c-4143-8abc-b5999f2d403f
As the API returns it
{
"id": "56152c89-c24c-4143-8abc-b5999f2d403f",
"created_at": "2026-10-01T04:03:43.579649Z",
"company_name": "Astrocyte Pharmaceuticals",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 9500000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Astrocyte Pharmaceuticals completed a $9.5M Series B financing and advanced enrollment in its Phase 2 STARFAST trial for AST-004, a cerebroprotective treatment for concussion.*"
}